Methods and systems for detecting cancer via nucleic acid methylation analysis
AssigneeFreenome Holdings, Inc.
InventorsShivani Mahajan, Billie Gould, Peter Ulz
Life of this patent
Estimating the term…
Loading patent…
AssigneeFreenome Holdings, Inc.
InventorsShivani Mahajan, Billie Gould, Peter Ulz
Estimating the term…
The present disclosure provides methods and systems for screening or detecting a tumor or following disease progression that may be applied to cell-free nucleic acids, such as cell-free DNA. The method may use detection of methylation signals within a single sequencing read in identified genomic regions as input features to train a machine learning model and generate a classifier useful for stratifying populations of individuals. The method may comprise extracting DNA from a cell-free sample obtained from a subject, converting the DNA for methylation sequencing, generating sequencing reads, detecting proliferative cell disorder-associated signals in the sequencing information, and training a machine learning model to provide a discriminator capable of distinguishing groups in a subject population such as healthy, cancer, or distinguishing disease subtype or stage. The method may be used for, e.g., predicting, prognosticating, and/or monitoring response to treatment, tumor load, relapse, or cancer development.
A method of treating a colorectal cancer in a subject using a computer specifically programmed to detect the colorectal cancer, the method comprising:
Dependencies are inferred from the claim text.